Extracorporeal Membrane Oxygenation Market Size By Modality (Venoarterial, Veno-venous, Arteriov0enous), By Application (Cardiac, Respiratory, Extracorporeal Cardiopulmonary Resuscitation), By Patient Population (Infant, Pediatric, Adult), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Aug 2019  |  Report ID: GMI2720  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 141   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Report Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Global extracorporeal membrane oxygenation industry 3600 synopsis, 2014 - 2025

2.1.1. Business trends

2.1.2. Modality trends

2.1.3. Application trends

2.1.4. Patient population trends

2.1.5. Regional trends

Chapter 3. Extracorporeal Membrane Oxygenation Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 – 2025

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Increase in cases of cardiopulmonary diseases and respiratory failure in Asia Pacific

3.3.1.2. Technological advancements in ECMO device in North America

3.3.1.3. Rising patient awareness about benefits delivered by extracorporeal membrane oxygenation device in Latin America

3.3.1.4. Rising government initiatives and programs in Europe

3.3.2. Industry pitfalls & challenges

3.3.2.1. High costs of equipment

3.3.2.2. Dearth of skilled professionals

3.3.2.3. Risks related to ECMO device

3.4. Growth potential analysis

3.4.1. By modality

3.4.2. By application

3.4.3. By patient population

3.5. Regulatory landscape

3.5.1. U.S

3.5.2. Europe

3.6. Porter’s analysis

3.7. Competitive landscape, 2018

3.7.1. Strategy dashboard

3.8. PESTEL analysis

Chapter 4. Extracorporeal Membrane Oxygenation Market, By Modality

4.1. Key segment trends

4.2. Venoarterial (VA)

4.2.1. Market size, by region, 2014 - 2025

4.3. Veno-venous (VV)

4.3.1. Market size, by region, 2014 - 2025

4.4. Arteriovenous (AV)

4.4.1. Market size, by region, 2014 - 2025

Chapter 5. Extracorporeal Membrane Oxygenation Market, By Application

5.1. Key segment trends

5.2. Cardiac diseases

5.2.1. Market size, by region, 2014 - 2025

5.3. Respiratory diseases

5.3.1. Market size, by region, 2014 - 2025

5.4. Extracorporeal cardiopulmonary resuscitation (ECPR)

5.4.1. Market size, by region, 2014 - 2025

Chapter 6. Extracorporeal Membrane Oxygenation Market, By Patient Population

6.1. Key segment trends

6.2. Infant

6.2.1. Market size, by region, 2014 - 2025

6.3. Pediatric

6.3.1. Market size, by region, 2014 – 2025

6.4. Adult

6.4.1. Market size, by region, 2014 - 2025

Chapter 7. Extracorporeal Membrane Oxygenation Market, By Region

7.1. Key regional trends

7.2. North America

7.2.1. Market size, by country, 2014 - 2025

7.2.2. Market size, by modality, 2014 - 2025

7.2.3. Market size, by application, 2014 – 2025

7.2.4. Market size, by patient population, 2014 – 2025

7.2.5. U.S.

7.2.5.1. Market size, by modality, 2014 - 2025

7.2.5.2. Market size, by application, 2014 – 2025

7.2.5.3. Market size, by patient population, 2014 – 2025

7.2.6. Canada

7.2.6.1. Market size, by modality, 2014 - 2025

7.2.6.2. Market size, by application, 2014 – 2025

7.2.6.3. Market size, by patient population, 2014 – 2025

7.3. Europe

7.3.1. Market size, by country, 2014 - 2025

7.3.2. Market size, by modality, 2014 - 2025

7.3.3. Market size, by application, 2014 – 2025

7.3.4. Market size, by patient population, 2014 – 2025

7.3.5. Germany

7.3.5.1. Market size, by modality, 2014 - 2025

7.3.5.2. Market size, by application, 2014 – 2025

7.3.5.3. Market size, by patient population, 2014 – 2025

7.3.6. UK

7.3.6.1. Market size, by modality, 2014 - 2025

7.3.6.2. Market size, by application, 2014 – 2025

7.3.6.3. Market size, by patient population, 2014 – 2025

7.3.7. France

7.3.7.1. Market size, by modality, 2014 - 2025

7.3.7.2. Market size, by application, 2014 – 2025

7.3.7.3. Market size, by patient population, 2014 – 2025

7.3.8. Italy

7.3.8.1. Market size, by modality, 2014 - 2025

7.3.8.2. Market size, by application, 2014 – 2025

7.3.8.3. Market size, by patient population, 2014 – 2025

7.3.9. Spain

7.3.9.1. Market size, by modality, 2014 - 2025

7.3.9.2. Market size, by application, 2014 – 2025

7.3.9.3. Market size, by patient population, 2014 – 2025

7.4. Asia Pacific

7.4.1. Market size, by country, 2014 - 2025

7.4.2. Market size, by modality, 2014 - 2025

7.4.3. Market size, by application, 2014 – 2025

7.4.4. Market size, by patient population, 2014 – 2025

7.4.5. Japan

7.4.5.1. Market size, by modality, 2014 - 2025

7.4.5.2. Market size, by application, 2014 – 2025

7.4.5.3. Market size, by patient population, 2014 – 2025

7.4.6. China

7.4.6.1. Market size, by modality, 2014 - 2025

7.4.6.2. Market size, by application, 2014 – 2025

7.4.6.3. Market size, by patient population, 2014 – 2025

7.4.7. India

7.4.7.1. Market size, by modality, 2014 - 2025

7.4.7.2. Market size, by application, 2014 – 2025

7.4.7.3. Market size, by patient population, 2014 – 2025

7.4.8. Taiwan

7.4.8.1. Market size, by modality, 2014 - 2025

7.4.8.2. Market size, by application, 2014 – 2025

7.4.8.3. Market size, by patient population, 2014 – 2025

7.5. Latin America

7.5.1. Market size, by country, 2014 - 2025

7.5.2. Market size, by modality, 2014 - 2025

7.5.3. Market size, by application, 2014 – 2025

7.5.4. Market size, by patient population, 2014 – 2025

7.5.5. Brazil

7.5.5.1. Market size, by modality, 2014 - 2025

7.5.5.2. Market size, by application, 2014 – 2025

7.5.5.3. Market size, by patient population, 2014 – 2025

7.5.6. Mexico

7.5.6.1. Market size, by modality, 2014 - 2025

7.5.6.2. Market size, by application, 2014 – 2025

7.5.6.3. Market size, by patient population, 2014 – 2025

7.5.7. Argentina

7.5.7.1. Market size, by modality, 2014 - 2025

7.5.7.2. Market size, by application, 2014 – 2025

7.5.7.3. Market size, by patient population, 2014 – 2025

7.6. Middle East & Africa

7.6.1. Market size, by country, 2014 - 2025

7.6.2. Market size, by modality, 2014 - 2025

7.6.3. Market size, by application, 2014 – 2025

7.6.4. Market size, by patient population, 2014 – 2025

7.6.5. Saudi Arabia

7.6.5.1. Market size, by modality, 2014 - 2025

7.6.5.2. Market size, by application, 2014 – 2025

7.6.5.3. Market size, by patient population, 2014 – 2025

7.6.6. Qatar

7.6.6.1. Market size, by modality, 2014 - 2025

7.6.6.2. Market size, by application, 2014 – 2025

7.6.6.3. Market size, by patient population, 2014 – 2025

7.6.7. UAE

7.6.7.1. Market size, by modality, 2014 - 2025

7.6.7.2. Market size, by application, 2014 – 2025

7.6.7.3. Market size, by patient population, 2014 – 2025

7.6.8. South Africa

7.6.8.1. Market size, by modality, 2014 - 2025

7.6.8.2. Market size, by application, 2014 – 2025

7.6.8.3. Market size, by patient population, 2014 – 2025

Chapter 8. Company Profiles

8.1. Abbott Laboratories

8.1.1. Business overview

8.1.2. Financial data

8.1.3. Product landscape

8.1.4. Strategic outlook

8.1.5. SWOT analysis

8.2. Alung Technologies

8.2.1. Business overview

8.2.2. Financial data

8.2.3. Product landscape

8.2.4. Strategic outlook

8.2.5. SWOT analysis

8.3. Braile Biomedical

8.3.1. Business overview

8.3.2. Financial data

8.3.3. Product landscape

8.3.4. Strategic outlook

8.3.5. SWOT analysis

8.4. Edwards Lifesciences Corp

8.4.1. Business overview

8.4.2. Financial data

8.4.3. Product landscape

8.4.4. Strategic outlook

8.4.5. SWOT analysis

8.5. Elsius Biomedical Inc.

8.5.1. Business overview

8.5.2. Financial data

8.5.3. Product landscape

8.5.4. Strategic outlook

8.5.5. SWOT analysis

8.6. Eurosets Srl

8.6.1. Business overview

8.6.2. Financial data

8.6.3. Product landscape

8.6.4. Strategic outlook

8.6.5. SWOT analysis

8.7. Getinge Group

8.7.1. Business overview

8.7.2. Financial data

8.7.3. Product landscape

8.7.4. Strategic outlook

8.7.5. SWOT analysis

8.8. LivaNova PLC

8.8.1. Business overview

8.8.2. Financial data

8.8.3. Product landscape

8.8.4. Strategic outlook

8.8.5. SWOT analysis

8.9. Medtronic Inc.

8.9.1. Business overview

8.9.2. Financial data

8.9.3. Product landscape

8.9.4. Strategic outlook

8.9.5. SWOT analysis

8.10. MicroPort Scientific Corporation

8.10.1. Business overview

8.10.2. Financial data

8.10.3. Product landscape

8.10.4. Strategic outlook

8.10.5. SWOT analysis

8.11. Nipro Corporation

8.11.1. Business overview

8.11.2. Financial data

8.11.3. Product landscape

8.11.4. Strategic outlook

8.11.5. SWOT analysis

8.12. Origen Biomedical

8.12.1. Business overview

8.12.2. Financial data

8.12.3. Product landscape

8.12.4. Strategic outlook

8.12.5. SWOT analysis

8.13. Spectrum Medical

8.13.1. Business overview

8.13.2. Financial data

8.13.3. Product landscape

8.13.4. Strategic outlook

8.13.5. SWOT analysis

8.14. Terumo Corporation

8.14.1. Business overview

8.14.2. Financial data

8.14.3. Product landscape

8.14.4. Strategic outlook

8.14.5. SWOT analysis

 

Data Tables

TABLE 1    Extracorporeal membrane oxygenation industry 360° synopsis, 2014 – 2025

TABLE 2    Global extracorporeal membrane oxygenation market, 2014 – 2025 (USD Million)

TABLE 3    Global ECMO market, by modality, 2014 – 2025 (USD Million)

TABLE 4    Global ECMO market, by application, 2014 – 2025 (USD Million)

TABLE 5    Global ECMO market, by patient population, 2014 – 2025 (USD Million)

TABLE 6    Global ECMO market, by region, 2014 – 2025 (USD Million)

TABLE 7    Industry impact forces

TABLE 8    Venoarterial (VA) market, by region, 2014 - 2025, (USD Million)

TABLE 9    Veno-venous (VV)market, by region, 2014 - 2025, (USD Million)

TABLE 10    Arteriovenous (AV) market, by region, 2014 - 2025, (USD Million)

TABLE 11    Cardiac diseases market, by region, 2014 - 2025, (USD Million)

TABLE 12    Respiratory diseases market, by region, 2014 - 2025, (USD Million)

TABLE 13    ECPR market, by region, 2014 - 2025, (USD Million)

TABLE 14    Infant market, by region, 2014 - 2025, (USD Million)

TABLE 15    Pediatric market, by region, 2014 - 2025, (USD Million)

TABLE 16    Adult (VA) market, by region, 2014 - 2025, (USD Million)

TABLE 17    North America ECMO market, by country, 2014 - 2025 (USD Million)

TABLE 18    North America ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 19    North America ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 20    North America ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 21    U.S. ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 22    U.S. ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 23    U.S. ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 24    Canada ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 25    Canada ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 26    Canada ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 27    Europe ECMO market, by country, 2014 - 2025 (USD Million)

TABLE 28    Europe ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 29    Europe ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 30    Europe ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 31    Germany ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 32    Germany ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 33    Germany ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 34    UK ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 35    UK ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 36    UK ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 37    Italy ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 38    Italy ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 39    Italy ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 40    Spain ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 41    Spain ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 42    Spain ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 43    France ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 44    France ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 45    France ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 46    Asia Pacific ECMO market, by country, 2014 - 2025 (USD Million)

TABLE 47    Asia Pacific ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 48    Asia Pacific ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 49    Asia Pacific ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 50    China ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 51    China ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 52    China ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 53    India ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 54    India ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 55    India ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 56    Japan ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 57    Japan ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 58    Japan ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 59    Taiwan ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 60    Taiwan ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 61    Taiwan ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 62    Latin America ECMO market, by country 2014 – 2025 (USD Million)

TABLE 63    Latin America ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 64    Latin America ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 65    Latin America ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 66    Argentina ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 67    Argentina ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 68    Argentina ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 69    Brazil ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 70    Brazil ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 71    Brazil ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 72    Mexico ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 73    Mexico ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 74    Mexico ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 75    MEA ECMO market, by country 2014 – 2025 (USD Million)

TABLE 76    MEA ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 77    MEA ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 78    MEA ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 79    South Africa ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 80    South Africa ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 81    South Africa ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 82    UAE ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 83    UAE ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 84    UAE ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 85    Saudi Arabia ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 86    Saudi Arabia ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 87    Saudi Arabia ECMO market, by patient population, 2014 - 2025 (USD Million)

TABLE 88    Qatar ECMO market, by modality, 2014 - 2025 (USD Million)

TABLE 89    Qatar ECMO market, by application, 2014 - 2025 (USD Million)

TABLE 90    Qatar ECMO market, by patient population, 2014 - 2025 (USD Million)
 

Charts & Figures

FIG. 1    Industry segmentation

FIG. 2    Global ECMO market, 2014 – 2025 (USD Million)

FIG. 3    Growth potential analysis, by modality

FIG. 4    Growth potential analysis, by application

FIG. 5    Growth potential analysis, by patient population

FIG. 6    Porter’s analysis

FIG. 7    Strategic dashboard

FIG. 8    PESTEL analysis

 

 

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Aug 2019
  • Pages: 141
  • Tables: 90
  • Charts / Figures: 8
  • Companies covered: 14
  • Countries covered: 18

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X